AI-Driven Precision Care for Chronic Diseases

Abstract

Chronic diseases are among the leading causes of morbidity, mortality, disability, and healthcare expenditure worldwide. Conditions such as cardiovascular disease, diabetes, chronic kidney disease, chronic respiratory disease, cancer, and neurological disorders are characterized by prolonged disease trajectories, complex comorbidities, and substantial differences in individual responses to treatment. Conventional approaches to chronic disease management often depend on standardized clinical guidelines and episodic assessments, which may not fully capture the dynamic and heterogeneous nature of disease progression. Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), offers an opportunity to strengthen precision care by integrating large and diverse datasets and translating them into individualized predictions and clinical recommendations. AI can analyze electronic health records, laboratory results, imaging studies, physiological signals, genomic information, and patient-generated data to identify patterns associated with disease development and progression. Predictive models can estimate an individual’s risk of complications, hospitalization, treatment failure, or mortality, allowing clinicians to identify high-risk patients before severe deterioration occurs. In cardiovascular disease, AI-enabled electrocardiography can identify subclinical abnormalities and predict heart failure, arrhythmias, and major adverse cardiovascular events. Similarly, AI-based models in chronic kidney disease can combine laboratory and clinical variables to predict renal function decline and progression toward kidney failure. AI-driven precision care can support individualized treatment selection by considering patient-specific characteristics, comorbidities, previous treatment responses, and longitudinal disease patterns. In diabetes, predictive algorithms can support glucose management and identify patients at increased risk of acute and chronic complications. In oncology, AI can integrate molecular, imaging, and clinical information to assist treatment selection and predict therapeutic response. These capabilities may improve clinical decision-making while reducing unnecessary interventions and supporting more effective resource utilization. The integration of AI with wearable devices, mobile applications, telemedicine platforms, and home monitoring systems enables continuous assessment of patients with chronic diseases. Physiological signals such as heart rate, blood pressure, oxygen saturation, glucose levels, physical activity, and sleep patterns can be analyzed to identify early changes in health status. This approach can facilitate timely intervention, reduce preventable hospitalizations, and extend personalized care beyond conventional clinical settings. Despite its potential, AI-driven chronic disease care faces challenges related to data quality, algorithmic bias, interpretability, privacy, interoperability, regulatory oversight, and clinical validation. AI should therefore complement rather than replace clinical expertise. Future progress will depend on prospective validation, equitable datasets, explainable models, seamless integration into clinical workflows, and collaboration between clinicians, patients, and technology developers. Ultimately, AI-driven precision care has the potential to transform chronic disease management from episodic and reactive care toward continuous, predictive, preventive, and individualized healthcare.